# Duanben Pharmaceutical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/duanben-pharmaceutical

- Industry: Pharmaceuticals
- Headquarters: Hangzhou, China
- Website: www.dbpharm.net
- Latest round: Series A (Feb 28, 2024)
- Investors on record: 2

## About

Based in Hangzhou, China, and founded in 2020, Duanben Pharmaceutical is a medical company focusing on the development of the health industry. which is incubated by Zhejiang Tianshi Biopharmaceutical. In December 2023, the company signed a strategic cooperation with Baicheng Pharmaceutical. In February 2024, it closed a series A funding.

The company is dedicated to pharmaceutical product research and development, product certification, pharmaceutical distribution, pharmaceutical promotion services, and so on. It also provides therapeutic products for orthopedics, digestion, anesthesia, and other departments. Its listed products adopt a pharmaceutical distribution method of direct sales and agency sales.

## Funding rounds

- Series A, Feb 28, 2024 — Hangzhou Xiaochi Private Equity Fund Management, Pufeng Venture Capital

## Investors

- Hangzhou Xiaochi Private Equity Fund Management (https://capitalatlas.ai/funds/hangzhou-xiaochi-private-equity-fund-management) — Series A
- Pufeng Venture Capital — Series A